| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |